A-Labs Capital IV Corp. is a listed company. Filings by its managers are published through SEDI. From 24 October 2025 to 24 October 2026, the disclosure feed for A-Labs Capital IV Corp. logged 2 filings by 2 insiders.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Across the 2,472 companies tracked on its exchange, the median is 13 filings; at 2 filings, this issuer sits below that mark.
Insider buying of A-Labs Capital IV Corp. has been absent for the past year.
This summary is built from SEDI disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
6 of 6 declarations
A-Labs Capital IV Corp. is an investment company listed on the Toronto Stock Exchange, focused on financing innovative projects. It aims to support early-stage and growth-stage companies.